Skip to main content
Premium Trial:

Request an Annual Quote

CDC and FDA in Transition

President-elect Barack Obama is about to name new heads of the CDC and FDA, says this story in the Wall Street Journal. Julie Gerberding will step down as CDC director to be replaced by William Gimson III, the CDC's COO, for the transition. Possible permanent choices include James Marks, a former senior CDC official and now a senior vice president at the Robert Wood Johnson Foundation; Helene Gayle, former CDC director for HIV/AIDS and president and CEO of CARE; and Thomas Frieden, commissioner of the New York City Department of Health and Mental Hygiene.

FDA's current science chief, Frank Torti, will serve as acting director until a permanent replacement is named. He was chosen to fill the temp spot over Janet Woodcock, director of the drug division who is currently "under fire from Congress in relation to several drug-safety issues, including the importation of contaminated heparin from China," reports the WSJ.

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.